Clinical Trial

Clinical Evaluation of the RH210 Hearing Aid

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-30
Trial Details
NCT Number NCT07572357
Lead Sponsor Rehear Audiology Company LTD
Collaborators: Global Edge Medtech Consulting, National Acoustic Laboratories
Conditions Hearing Impairment, Sensorineural, Perceived Hearing Loss
Enrollment 24 participants
Start Date 2026-04-11
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-29